The weight loss pill Meridia may increase the risk of heart attacks, according to a company-sponsored study, and is set for review by the FDA next week.
New research indicates that Meridia, a weight loss pill manufactured by Abbott Laboratories, may increase the risk of heart attacks, prompting consumer advocates to call for the drug to be pulled from the U.S. market.
 Solar Power Design Manual.Teach Yourself Solar PowerFinally, an easy-to-follow guide to generating power from the sun, anywhere. The Solar Power Design Manual Ebook starts from first principles to guide you through the process of designing, specifying and installing your own self-contained solar power system, anywhere in the world. Read More: Visit Publisher Site |
The study, published in the New England Journal of Medicine , examined more than 10,000 people over the age of 55 who were overweight or obese and had pre-existing heart disease, type 2 diabetes or both. Each person was given either Meridia or a placebo and participated in a diet and exercise program. The study found that on average when Meridia was taken for more than three years, the risk of having a heart attack or stroke was 16 percent higher. Researchers found no increased mortality rate, but Meridia patients did see an increase in heart rate and blood pressure.
The Food and Drug Administration (FDA)
Click here to view rest of article from original site
|
||||||
|
|
||||||
